Fungal Infections Clinical Trial
Official title:
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
The main goal of this study is to see how the body breaks down an antifungal drug named posaconazole in children with certain cancers, blood disorders, or transplantation of bone marrow or similar blood cells. This study will also help us learn whether a child's age, genetics, or disease affect how well the body breaks down posaconazole.
The purpose of this research study is to see how the body breaks down posaconazole, which has limited data in children. Posaconazole injection has been approved by the FDA for prevention or treatment of certain fungal infections in adult patients. In children, however, we don't have data on how best to give posaconazole or whether the dosing should be personalized to individual children. This study aims to determine pharmacokinetics of posaconazole aqueous solution for injection in children aged 2 through 17 years and explores differences in drug exposure by age, genetics, and disease state. Children will receive a single dose of posaconazole injection and have their blood levels of posaconazole checked. The study will also check for safety after giving the posaconazole. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01782131 -
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
|
Phase 3 | |
| Completed |
NCT02631954 -
Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00177684 -
Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
|
Phase 3 | |
| Recruiting |
NCT01684189 -
Registry of Febrile Neutropenia and Invasive Fungal Infections
|
N/A | |
| Completed |
NCT00794703 -
A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections
|
Phase 3 | |
| Completed |
NCT00606268 -
A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant
|
Phase 1 | |
| Completed |
NCT00353158 -
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
|
Phase 1 | |
| Completed |
NCT01777763 -
Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)
|
Phase 1 | |
| Recruiting |
NCT01222741 -
Studies of Disorders With Increased Susceptibility to Fungal Infections
|
||
| Completed |
NCT00177710 -
Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study
|
Phase 3 | |
| Enrolling by invitation |
NCT03793231 -
fungalAi for Fungal Surveillance & Antifungal Stewardship
|
||
| Completed |
NCT02025699 -
Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis
|
N/A | |
| Completed |
NCT01436578 -
Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)
|
N/A | |
| Completed |
NCT00876096 -
Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal Infections
|
N/A | |
| Completed |
NCT02306330 -
MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial
|
N/A | |
| Not yet recruiting |
NCT01105013 -
Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections
|
Phase 3 | |
| Terminated |
NCT01716234 -
A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)
|
Phase 1 | |
| Recruiting |
NCT05336851 -
Emergency PWAS in Respiratory Infectious Disease
|